United States Zika Cases In week 34 MMWR Increase 162

[niman]

Zika ††,§§§§
Zika virus congenital infection	NA	NA	NA	NN	NN	NN	NN	NN
Zika virus disease, non-congenital infection	6	2,580	-	NN	NN	NN	NN	NN	NYC (3 ), MD (1 ), GA (1 ), TN (1 )

http://wonder.cdc.gov/mmwr/mmwr_2016.asp?mmwr_year=2016&mmwr_week=34&mmwr_table=1&request=Submit&mmwr_location=

[niman]

TABLE I. Provisional cases of selected* infrequently reported notifiable diseases (<1,000 cases reported during the preceding year), United States,  week ending August 27, 2016 (WEEK 34)†     Disease   Total cases reported for previous years   Current week Cum 2016 5-year weekly average§ 2015 2014 2013 2012 2011 States reporting cases during current week (No.34)  Anthrax - - - - - - - 1    Arboviral diseases ¶,**:                    Chikungunya virus †† - 64 6 896 NN NN NN NN    Eastern equine encephalitis virus - 1 1 6 8 8 15 4    Jamestown Canyon virus §§ - 2 0 11 11 22 2 3    La Crosse virus §§ - 5 2 55 80 85 78 130    Powassan virus - 4 0 7 8 12 7 16    St. Louis encephalitis virus - 1 0 23 10 1 3 6    Western equine encephalitis virus - - - - - - - -    Botulism, total - 111 3 195 161 152 168 153    foodborne - 26 1 37 15 4 27 24    infant - 72 2 138 127 136 123 97    other(wound & unspecified) - 13 0 20 19 12 18 32    Brucellosis 3 75 3 126 92 99 114 79 FL (1 ), OK (1 ), TX (1 )  Chancroid - 8 0 11 - - 15 8    Cholera - - 0 2 5 14 17 40    Cyclosporiasis ** 9 304 16 645 388 784 123 151 NY (1 ), NYC (2 ), OH (1 ), NE (1 ), FL (1 ), TX (3 )  Diphtheria - - - - 1 - 1 -    Haemophilus influenzae, invasive disease (age <5 yrs) ¶¶:                    serotype b - 11 1 29 40 31 30 14    nontypeable serotype - 94 2 175 128 141 115 93    other serotype - 77 1 135 266 233 263 230    unknown serotype 5 136 3 167 39 34 37 48 OH (2 ), MD (1 ), FL (1 ), TX (1 )  Hansen's disease ** 2 28 1 89 88 81 82 82 FL (2 )  Hantavirus Infections **:                    Hantavirus infection (non-HPS) †† - 2 0 1 NN NN NN NN    Hantavirus pulmonary syndrome (HPS) - 10 0 17 32 21 30 23    Hemolytic uremic syndrome, post-diarrheal ** 8 132 8 274 250 329 274 290 OH (2 ), MD (1 ), OK (5 )  Hepatitis B, virus infection perinatal 1 17 1 37 47 48 40 NP PA (1 )  Influenza-associated pediatric mortality **, *** - 79 1 130 141 160 52 118    Leptospirosis ** 1 23 1 40 38 NN NN NN MD (1 )  Listeriosis 9 352 23 766 769 735 727 870 NY (1 ), NYC (1 ), OH (1 ), MD (1 ), FL (2 ), OK (2 ), TX (1 )  Measles ††† - 51 3 188 667 187 55 220    Meningococcal disease, invasive §§§:                    serogroup ACWY 1 59 2 120 123 142 161 257 SC (1 )  serogroup B - 48 1 111 89 99 110 159    other serogroup - 12 0 21 25 17 20 20    unknown serogroup 1 124 3 120 196 298 260 323 GA (1 )  Novel influenza A virus infections ¶¶¶ 7 21 11 6 3 21 313 14 MI (4 ), OH (3 )  Plague - - 0 13 10 4 4 3    Poliomyelitis, paralytic - - - - - 1 - -    Polio virus infection, nonparalytic ** - - - - - - - -    Psittacosis ** - 4 0 4 8 6 2 2    Q fever total **: 2 71 4 156 168 170 135 134    acute 1 59 3 122 132 137 113 110 OK (1 )  chronic 1 12 1 34 36 33 22 24 PA (1 )  Rabies, human - - 0 1 1 2 1 6    SARS CoV - - - - - - - -    Smallpox - - - - - - - -    Streptococcal toxic shock syndrome ** - 167 2 335 259 224 194 168    Syphilis, congenital **** - 216 8 490 458 348 322 360    Toxic shock syndrome (staphylococcal) ** - 19 2 64 59 71 65 78    Trichinellosis ** 1 8 0 11 14 22 18 15 AK (1 )  Tularemia 4 117 6 314 180 203 149 166 MO (1 ), NE (1 ), OK (1 ), CO (1 )  Typhoid fever 3 188 9 367 349 338 354 390 NY (3 )  Vancomycin-intermediate Staphylococcus aureus ** - 64 3 183 212 248 134 82    Vancomycin-resistant Staphylococcus aureus ** - - 0 1 - - 2 -    Viral hemorrhagic Fevers ††††:                    Crimean-Congo hemorrhagic fever - - - - NP NP NP NP    Ebola hemorrhagic fever - - - - 4 NP NP NP    Guanarito hemorrhagic fever - - - - NP NP NP NP    Junin hemorrhagic fever - - - - NP NP NP NP    Lassa fever - - - - 1 NP NP NP    Lujo virus - - - - NP NP NP NP    Machupo hemorrhagic fever - - - - NP NP NP NP    Marburg fever - - - - NP NP NP NP    Sabia-associated hemorrhagic fever - - - - NP NP NP NP    Yellow fever - - - - - - - -    Zika ††,§§§§                    Zika virus congenital infection NA NA NA NN NN NN NN NN    Zika virus disease, non-congenital infection 6 2,580 - NN NN NN NN NN NYC (3 ), MD (1 ), GA (1 ), TN (1 ) [ Export This Table ]  [ Next Part ]  [ NNDSS Interactive Tables ]  [ Mortality Interactive Tables ]

-: No reported cases    N: Not reportable.    NA: Not Available    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.  * Case counts for reporting years 2015 and 2016 are provisional and subject to change. Data for years 2011 through 2014 are finalized. For further information on interpretation of these data, seehttp://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.  † This table does not include cases from the U.S. territories. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.  § Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. Additional information is available athttp://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf.  ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly reports from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.  ** Not reportable in all reporting jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated pediatric mortality. Reporting exceptions are available athttp://wwwn.cdc.gov/nndss/downloads.html.  †† Office of Management and Budget approval of the NNDSS Revision #0920-0728 on January 21, 2016, authorized CDC to receive data for these conditions. CDC is in the process of soliciting data for these conditions (except Zika virus, congenital infection). CDC and the U.S. states are still modifying the technical infrastructure needed to collect and transmit data for Zika virus congenital infections.  §§ Jamestown Canyon virus and Lacrosse virus have replaced California serogroup diseases.  ¶¶ Data for Haemophilus influenzae (all ages, all serotypes) are available in Table II.  *** Please refer to the MMWR publication for weekly updates to the footnote for this condition.  ††† Please refer to the MMWR publication for weekly updates to the footnote for this condition.  §§§ Data for meningococcal disease (all serogroups) are available in Table II.  ¶¶¶ Please refer to the MMWR publication for weekly updates to the footnote for this condition.  **** Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.  †††† Please refer to the MMWR publication for weekly updates to the footnote for this condition.  §§§§ All cases reported have occurred in travelers returning from affected areas, with their sexual contacts, or infants infected in utero. National Notifiable Diseases Surveillance System (NNDSS) MMWR web application provided by CDC WONDER,  http://wonder.cdc.gov